U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Vaccines
  4. Biothrax
  1. Vaccines

STN: BL 103821
Proper Name: Anthrax Vaccine Adsorbed
Tradename: Biothrax
Manufacturer: Emergent BioDefense Operations Lansing LLC
Indications:

  • For the active immunization for the prevention of disease caused by Bacillus anthracis in persons 18 through 65 years of age.
  • BioThrax is approved for:
  1. Pre-exposure prophylaxis of disease in persons at high risk of exposure.
  2. Post-exposure prophylaxis of disease following suspected or confirmed Bacillus anthracis exposure, when administered in conjunction with recommended antibacterial drugs.

Product Information

Supporting Documents

Related Information

  • FDA Online Label Repository
    Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.
Back to Top